Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorthern Venture Trust Regulatory News (NVT)

Share Price Information for Northern Venture Trust (NVT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.50
Bid: 56.00
Ask: 59.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.357%)
Open: 57.50
High: 57.50
Low: 57.50
Prev. Close: 57.50
NVT Live PriceLast checked at -
Northern Venture Trust is an Investment Trust

To provide high long-term tax-free returns to investors through a combination of dividend yield and capital growth, by investing primarily in unquoted UK manufacturing and service businesses.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value

28 Jul 2023 15:30

Net Asset Value

28 July 2023

NORTHERN VENTURE TRUST PLC

UNAUDITED NET ASSET VALUE AS AT 30 JUNE 2023

Northern Venture Trust PLC (“the Company”) is a Venture Capital Trust (“VCT”) launched in 1995 and advised by Mercia Fund Management Limited. The Company’s objective is to provide high long-term tax-free returns to investors through a combination of dividend yield and capital growth, by investing in a portfolio of investments mainly comprising unquoted venture capital holdings. In order to maintain approval by HM Revenue & Customs as a VCT, the Company is required to comply on a continuing basis with the provisions of Section 274 of the Income Tax Act 2007.

The unaudited net asset value per ordinary share as at 30 June 2023 was 62.0 pence (31 March 2023: 62.1 pence).

For the purposes of calculating the net asset value per share, quoted investments are carried at bid price as at 30 June 2023 and unquoted investments are carried at fair value as at 30 June 2023 as determined by the directors.

New Investments:During the three months ended 30 June 2023 one new venture capital investment was completed.

Name of company Business activity Amount invested£ million
Camena Bioscience LtdProvider of synthetic DNA1.6

In addition to the new investment above, £1.1 million was invested in three existing portfolio companies during the quarter.

Realisations:During the three months ended 30 June 2023 one venture capital investment was realised.

Name of company Sale proceeds Original cost Carrying value at 31 March 2023
 £ million£ million£ million
Evotix Ltd12.72.812.7

The number of ordinary shares in issue at 30 June 2023 was 174,661,348. During the three months ended 30 June 2023 9,741,182 shares were allotted pursuant to the Company’s 2022/23 public share offer.

Enquiries:

Sarah Williams / James Sly, Mercia Fund Management Ltd – 0330 223 1430Website: www.mercia.co.uk/vcts

The contents of the Mercia Asset Management PLC website and the contents of any website accessible from hyperlinks on the Mercia Asset Management PLC website (or any other website), are not incorporated into, nor forms part of, this announcement.

Date   Source Headline
21st Dec 201812:00 pmGNWIssue of Equity
14th Dec 20181:00 pmGNWResult of AGM
30th Nov 20182:00 pmGNWTotal voting rights
26th Nov 20184:00 pmGNWTransaction in Own Shares
23rd Nov 20183:30 pmGNWStatement regarding Top up offer
22nd Nov 20184:15 pmGNWTransaction in Own Shares
16th Nov 201812:30 pmGNWAnnual Financial Report
12th Nov 201812:30 pmGNWAnnual Financial Report
28th Sep 20183:45 pmGNWTotal voting rights
28th Sep 20183:30 pmGNWTransaction in Own Shares
31st Jul 20189:00 amGNWTotal voting rights
9th Jul 201810:00 amGNWTransaction in own shares
29th Jun 20181:00 pmGNWNotification of Transaction by Person Discharging Managerial Responsibilities (“PDMR”)
29th Jun 20181:00 pmGNWNotification of Transaction by Person Discharging Managerial Responsibilities ("PDMR")
29th Jun 20181:00 pmGNWNotification of Transaction by Person Discharging Managerial Responsibilities (“PDMR”)
15th Jan 201010:31 amRNSTransaction in Own Shares
14th Jan 20106:01 pmRNSResult of Annual General Meeting
7th Aug 20095:22 pmRNSTransaction in Own Shares
7th Aug 20094:43 pmRNSNet Asset Value(s)
13th Mar 200910:32 amRNSIssue of Ordinary Shares and Total Voting Rights
27th Feb 200912:28 pmRNSIssue of New Ordinary Shares
13th Feb 200912:03 pmRNSInterim Management Statement
23rd Jan 200910:42 amRNSIssue of Equity and Total Voting Rights
14th Jan 20094:26 pmRNSResult of AGM
17th Dec 200812:25 pmRNSAnnual Information Update
19th Nov 20083:23 pmRNSDirector/PDMR Shareholding
14th Nov 200812:06 pmRNSFinal Results
4th Nov 20082:56 pmRNSTotal Voting Rights
10th Oct 20089:27 amRNSIssue of Equity
30th Sep 200811:54 amRNSPurchase of Own Shares
30th Sep 200811:53 amRNSTotal Voting Rights
16th Sep 200811:03 amRNSPurchase of Own Shares
11th Sep 20081:40 pmRNSDividend Declaration
29th Jul 20084:50 pmRNSInterim Management Statement
4th Jul 20082:41 pmRNSResult of General Meeting
1st Jul 200810:25 amRNSTotal Voting Rights
27th Jun 20082:31 pmRNSIssue of Equity
30th May 20083:33 pmRNSAmendments to Articles of Ass
30th May 20082:11 pmRNSSale of Product Support (Hold
22nd May 20084:34 pmRNSDirector/PDMR Shareholding
20th May 20082:30 pmRNSInterim Results
22nd Feb 20082:18 pmRNSDirector/PDMR Shareholding
20th Feb 20084:15 pmRNSDirector/PDMR Shareholding
15th Feb 20082:15 pmRNSDirector/PDMR Shareholding
14th Feb 200811:44 amRNSInterim Management Statement
9th Jan 20083:43 pmRNSAnnual Information Update
2nd Jan 200811:48 amRNSTotal Voting Rights
17th Dec 20071:27 pmRNSDirector/PDMR Shareholding
14th Dec 20079:34 amRNSIssue of Equity
14th Dec 20079:32 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.